Cancer and Leukemia Group B

癌症和白血病 B 组

• 批准号: 8063655
• 负责人: CLIFFORD A HUDIS
• 金额: $ 20.12万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-07-30 至 2015-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8063655
• 关键词: Ally; Area; Basic Science; Cancer Center; Cancer Hospital; Cancer and Leukemia Group B; Clinical; Clinical Research; Commit; Detection; Diagnosis; Disease; Grant; Hospitals; Institutes; Institution; Intention; Laboratories; Leadership; Malignant Neoplasms; Memorial Sloan-Kettering Cancer Center; Modality; Outpatients; Patient Care; Patients; Physicians; Policies; Positioning Attribute; Prevention; Research; Research Personnel; Research Training; Scientist; Testing; Training Programs; anticancer research; base; design; patient population; programs; research facility; success

DESCRIPTION (provided by applicant): Memorial Sloan-Kettering Cancer Center (MSKCC) is the largerst privately owneed nonprofit cancer center in the world. The Center consists of 3 corporations. Memorial Hospital for Cancer and Allied Diseases, foundin in 1884 is the clinical unit; Sloan-Kettering Institute for Cancer Research, founded in 1945 is the basic research unit; and Memorial Sloan-Kettering Cancer Center, founded in 1960 is the unit that formulates policies and long-range plans and coordinates the activities of the hospital and the institute. MSKCC is a free-standing institution committed to exceptional in-patient and out-patient care, leading edge research and superb clinical and research training programs. MSKCC's clinical research programs are synonymous with those of the Cancer and Leukemia Group B (CALGB). Physician-scientists at MSKCC hold leadership positions in the CALGB across an array of disease-specific areas and treatment modalities, with significant administrative responsibilities for the group. Scientific and clinical research programs at MSKCC are created with the intention of ultimately testing them, when possible, in the larger patient populations offered by our participation in the CALGB. During the next six years, MSKCC will continue to expand its clinical and research facilities as well as its research and training programs. The enclosed grant offers examples of MSKCC contributions to the success of the CALGB and support for MSKCC's continued participation.

描述（由申请人提供）：纪念斯隆-凯特琳癌症中心（MSKCC）是世界上最大的私人拥有的非营利性癌症中心。该中心由3个公司组成。癌症及相关疾病纪念医院成立于1884年，是临床单位；成立于1945年的斯隆-凯特林癌症研究所是基础研究单位；成立于1960年的纪念斯隆-凯特琳癌症中心是制定政策和长期计划并协调医院和研究所活动的单位。MSKCC是一家独立的机构，致力于卓越的住院和门诊护理，领先的研究和一流的临床和研究培训计划。MSKCC的临床研究项目是癌症和白血病B组（CALGB）的代名词。MSKCC的内科科学家在CALGB的一系列疾病特定领域和治疗方式中担任领导职务，对该小组负有重要的行政责任。MSKCC的科学和临床研究项目是为了在可能的情况下，在我们参与CALGB提供的更大的患者群体中最终测试它们而创建的。在接下来的六年中，MSKCC将继续扩大其临床和研究设施以及研究和培训计划。所附的奖助金提供了MSKCC对CALGB成功的贡献和对MSKCC继续参与的支持的例子。